# Artan Bio — machine-readable site summary
# https://www.artan.bio

> Artan Bio develops codon suppressor therapies designed to restore full-length
> protein translation where premature stop codons interrupt biology.

## Company

- Name: Artan Bio
- Focus: nonsense mutations, premature stop codons, translation rescue
- Lead program: ARTAN-102 (engineered tRNA suppressor system)
- Stage: preclinical

## Lead asset (ARTAN-102)

- Engineered tRNA suppressor system delivered via AAV9
- Restored full-length p53 in a preclinical Calu-6 R196X/R196X model
- Detected across six major mouse tissues in preclinical studies
- Post-chemo accelerated aging may provide a measurable first human
  proof-of-concept path (under discussion; not proven in humans)

## Key pages

- Home: https://artanbio-vita-dao.vercel.app/
- About / leadership: https://artanbio-vita-dao.vercel.app/about
- Partners: https://artanbio-vita-dao.vercel.app/partners
- Blog: https://artanbio-vita-dao.vercel.app/blog
- Contact: https://artanbio-vita-dao.vercel.app/contact

## What Artan Bio is not

- Not an approved therapy; all work is preclinical unless stated otherwise
- Does not claim to cure aging, prevent cancer, or guarantee regulatory approval
- Does not provide medical or investment advice on this site
- VitaRNA token/community is a separate ecosystem layer (not promoted on this site)

## Contact

- Web: https://artanbio-vita-dao.vercel.app/contact
- LinkedIn: https://www.linkedin.com/company/artan-bio/
- X: https://x.com/artan_bio